These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 10521425

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
    Heller RS, Kieffer TJ, Habener JF.
    Biochem Biophys Res Commun; 1996 Jun 25; 223(3):624-32. PubMed ID: 8687446
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
    Baggio LL, Huang Q, Brown TJ, Drucker DJ.
    Diabetes; 2004 Sep 25; 53(9):2492-500. PubMed ID: 15331566
    [Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
    Skoglund G, Hussain MA, Holz GG.
    Diabetes; 2000 Jul 25; 49(7):1156-64. PubMed ID: 10909973
    [Abstract] [Full Text] [Related]

  • 9. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
    Fehmann HC, Jiang J, Pitt D, Schweinfurth J, Göke B.
    Pancreas; 1996 Oct 25; 13(3):273-82. PubMed ID: 8884849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways.
    Koehler JA, Yusta B, Drucker DJ.
    Mol Endocrinol; 2005 Feb 25; 19(2):459-73. PubMed ID: 15471943
    [Abstract] [Full Text] [Related]

  • 15. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM, MacDonald PE, Gaisano HY, Wheeler MB.
    Mol Endocrinol; 1999 Aug 25; 13(8):1305-17. PubMed ID: 10446905
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.
    Estall JL, Yusta B, Drucker DJ.
    Mol Biol Cell; 2004 Aug 25; 15(8):3673-87. PubMed ID: 15169869
    [Abstract] [Full Text] [Related]

  • 18. The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38.
    Schulte G, Fredholm BB.
    Exp Cell Res; 2003 Oct 15; 290(1):168-76. PubMed ID: 14516797
    [Abstract] [Full Text] [Related]

  • 19. Insulinotropic hormone glucagon-like peptide 1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase.
    Kemp DM, Habener JF.
    Endocrinology; 2001 Mar 15; 142(3):1179-87. PubMed ID: 11181533
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.